Abnormal Angiogenesis and Cancer

Abnormal angiogenesis, the process of new blood vessel formation, plays a critical role in the development and progression of cancer. In diabetes, hyperglycemia and insulin resistance can exacerbate this process, leading to an increased risk of tumor growth and metastasis. Elevated glucose levels create a pro-inflammatory environment, stimulating the release of angiogenic factors such as vascular endothelial growth factor (VEGF). This, in turn, promotes excessive blood vessel formation, allowing tumors to receive the necessary nutrients and oxygen for their rapid growth. Furthermore, the altered vascular permeability in diabetic patients can facilitate cancer cell invasion and dissemination. Understanding the interplay between diabetes and angiogenesis is essential for developing targeted therapies aimed at both managing blood sugar levels and inhibiting tumor angiogenesis, ultimately improving cancer treatment outcomes in diabetic patients.